Akoya - רווח נקי למניה ב-12 החודשים האחרונים AKYA

Tissue analysis patents and revenue from consumables create a sustainable advantage for Akoya Biosciences (AKYA). Strategic partnerships with pharma behemoths are accelerating the implementation of cancer markers. Optimizing board assembly and logistics through outsourcing is stabilizing service. The TTM EPS dynamics reflect the outcome of these processes, where the 4.70 mark indicates the current earnings per share level.
Akoya Biosciences Inc - פילוחים אנליטיים ומדדי מפתח (AKYA)

This indicator captures the rate of change in earnings per share over the last twelve months. It allows for an assessment of real capital generation efficiency, adjusted for seasonality. By analyzing the EPS YoY TTM percentage trend, an investor determines the business growth stage and the risk of asset overvaluation. For Akoya Biosciences (AKYA), this trend reflects the monetization of customer dependence on unique consumables. High user loyalty to the company's proprietary technologies converts directly into the stability of this metric.